TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31617395

Group type: EXPERIMENTAL
Intervention: Home-based exercise and education programme
Number of subjects: 154
Study: 30256277

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (daily practice for 21 days)
Number of subjects: 90
Study: 27343788

Group type: EXPERIMENTAL
Intervention: Pheniramine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 22647558

Group type: EXPERIMENTAL
Intervention: Interprofessional SDM training program 'Fit for SDM'
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Application of the training content
Number of subjects: 6

Group type: COMPARATOR
Intervention: Training program
Number of subjects: 6
Study: 20559255

Group type: EXPERIMENTAL
Intervention: Viferon gel (0.5 ml, 4-5 times daily)
Number of subjects: 90
Study: 17572116

Group type: EXPERIMENTAL
Intervention: Zenith endograft
Number of subjects: 648

Group type: COMPARATOR
Intervention: Talent endograft
Number of subjects: 648
Study: 15713907

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 807

Group type: COMPARATOR
Intervention: Control group (no vitamin A supplementation)
Number of subjects: 807
Study: 12111469

Group type: EXPERIMENTAL
Intervention: Deprenyl washout
Number of subjects: 11
Study: 10586171

Group type: EXPERIMENTAL
Intervention: Cranberry concentrate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo concentrate
Number of subjects: 15
Study: 8598085

Group type: EXPERIMENTAL
Intervention: Forearm training for 6 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dynamic handgrip and posthandgrip regional circulatory occlusion (PH-RCO)
Number of subjects: 22
Study: 1874208

Group type: EXPERIMENTAL
Intervention: PGE1 30 ng kg‐1 min‐1
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no PGE1 administration)
Number of subjects: 15
Study: 6218964

Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA) administered on cycle day 5
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA) administered on cycle day 7
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA) administered on cycle day 9
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA) administered on cycle day 11
Number of subjects: 49
Study: 31884492

Group type: EXPERIMENTAL
Intervention: RAS-supported multimodal balance training
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Regular multimodal balance training
Number of subjects: 154
Study: 31272277

Group type: EXPERIMENTAL
Intervention: 3D-MOT combined with a decision-making task
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Consolidated 3D-MOT later combined with a decision-making task
Number of subjects: 57

Group type: COMPARATOR
Intervention: Isolated decision-making task
Number of subjects: 57

Group type: COMPARATOR
Intervention: Isolated 3D-MOT
Number of subjects: 57
Study: 26959873

Group type: EXPERIMENTAL
Intervention: Maximal countermovement jumps on two force platforms (1000 Hz) linked to a nine camera infrared motion capture system (500 Hz)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rehabilitation and conditioning exercises targeting frontal and transverse plane movement
Number of subjects: 18
Study: 25500669

Group type: EXPERIMENTAL
Intervention: Vapor ablation therapy targeting the most diseased segments of the lung, specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Segmental targeting using the segmental heterogeneity index for quantifying emphysema severity.
Number of subjects: 0
Study: 24867906

Group type: COMPARATOR
Intervention: Exercises only (Control Group 1, n=60)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Back school program and exercises (Group 2, n=61)
Number of subjects: 121
Study: 22840278

Group type: EXPERIMENTAL
Intervention: C+P (behavioral counseling and education followed by monthly phone calls for 6 months)
Number of subjects: 1155

Group type: COMPARATOR
Intervention: C (behavioral counseling and education at baseline)
Number of subjects: 1155

Group type: COMPARATOR
Intervention: S (standard care)
Number of subjects: 1155

Group type: EXPERIMENTAL
Intervention: C+P
Number of subjects: 1155

Group type: COMPARATOR
Intervention: C
Number of subjects: 1155

Group type: COMPARATOR
Intervention: S
Number of subjects: 1155
Study: 20600678

Group type: EXPERIMENTAL
Intervention: Tonal melodies
Number of subjects: 10

Group type: COMPARATOR
Intervention: Random notes
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tonal melodies and random notes
Number of subjects: 10
Study: 17664469

Group type: EXPERIMENTAL
Intervention: ECF (epirubicin 50 mg/m(2) on day 1, cisplatin 60 mg/m(2) on day 1, and fluorouracil 200 mg/m(2)/d on days 1 to 21)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: TC (docetaxel initially 85 mg/m(2) on day 1, later reduced to 75 mg/m(2), and cisplatin 75 mg/m(2) on day 1)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: TCF (TC plus FU 300 mg/m(2)/d on days 1 to 14)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 119
Study: 16129973

Group type: EXPERIMENTAL
Intervention: Desflurane at 12%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane at 3.6%
Number of subjects: 60
Study: 12072899

Group type: EXPERIMENTAL
Intervention: Pamidronate (60 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Untreated patients (n=5)
Number of subjects: 12
Study: 10091854

Group type: EXPERIMENTAL
Intervention: Cadmium-exposed workers
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cadmium body burden (urinary Cd)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Blood lead levels
Number of subjects: 32
Study: 7587255

Group type: EXPERIMENTAL
Intervention: Nursing index (1.05) with increased number of nurses
Number of subjects: 87

Group type: COMPARATOR
Intervention: Nursing index (less than 1.0) with diminished available workforce
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Nursing index compared with complications and duration of weaning
Number of subjects: 87
Study: 2246915

Group type: EXPERIMENTAL
Intervention: Low-dose sotalol (40 mg every 8 hours)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Low-dose propranolol (10 mg every 6 hours)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: High-dose sotalol (80 mg every 8 hours)
Number of subjects: 429

Group type: COMPARATOR
Intervention: High-dose propranolol (20 mg every 6 hours)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Low-dose sotalol
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: High-dose sotalol
Number of subjects: 429

Group type: COMPARATOR
Intervention: Low-dose propranolol
Number of subjects: 429

Group type: COMPARATOR
Intervention: High-dose propranolol
Number of subjects: 429
Study: 6818684

Group type: EXPERIMENTAL
Intervention: Low-lactose milk (85% of the lactose hydrolyzed)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ordinary cow milk (lactose content, 25 g)
Number of subjects: 11
Study: 30816670

Group type: EXPERIMENTAL
Intervention: T2DM + MVC group (n=30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: T2DM group (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NC group (n=30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Correlation of APN with clinical parameters
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Correlation of AdipoR1 with clinical parameters
Number of subjects: 60
Study: 29092881

Group type: EXPERIMENTAL
Intervention: Potassium chloride (KCl) supplements, 40 mEq/d for 3 months
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 25425297

Group type: EXPERIMENTAL
Intervention: Gla-300 (0.4, 0.6, and 0.9 U/kg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Gla-100 (0.4 U/kg)
Number of subjects: 42
Study: 24922046

Group type: EXPERIMENTAL
Intervention: High doses of rosuvastatin for 6 weeks before carotid artery stenting (CAS)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Direct carotid stenting without rosuvastatin pretreatment
Number of subjects: 130
Study: 18258584

Group type: EXPERIMENTAL
Intervention: Oral care and rinses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacologic interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other techniques
Number of subjects: 0
Study: 14732417

Group type: EXPERIMENTAL
Intervention: Personalized normative feedback (PNF)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Personal strivings assessment (PSA)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Attention-control
Number of subjects: 92
Study: 11205467

Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) with autologous stem-cell transplantation (ASCT)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) with ASCT (in patients < 65 years)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Standard treatment (in patients < 65 years)
Number of subjects: 372
Study: 9084194

Group type: EXPERIMENTAL
Intervention: Topical doxymycine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Calcii gluconase (Control)
Number of subjects: 31
Study: 8366182

Group type: EXPERIMENTAL
Intervention: Didanosine 300 mg chewable tablet after overnight fast
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Didanosine 300 mg chewable tablet 30 minutes before a meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Didanosine 300 mg chewable tablet 1 hour before a meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Didanosine 300 mg chewable tablet 1 hour after a meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Didanosine 300 mg chewable tablet 2 hours after a meal
Number of subjects: 10
Study: 3519020

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30647044

Group type: EXPERIMENTAL
Intervention: BDD-NET (therapist-guided internet-based cognitive behavioural therapy)
Number of subjects: 88
Study: 28306389

Group type: EXPERIMENTAL
Intervention: Inclisiran (200 mg, 300 mg, 500 mg single dose)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Inclisiran (100 mg, 200 mg, 300 mg two doses at days 1 and 90)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Inclisiran (300 mg two doses)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Inclisiran
Number of subjects: 501
Study: 25326088

Group type: EXPERIMENTAL
Intervention: Guidelines on treatment of RTIs and uncomplicated lower UTIs with sustained, regular feedback on individual antibiotic prescription behaviour during 2 years
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 140
Study: 25028096

Group type: EXPERIMENTAL
Intervention: Elemental carbon ultrafine particles (107 particles/cm3, 50 ug/m3, count median diameter 32 nm)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Filtered air (0-10 particles/cm3)
Number of subjects: 17
Study: 22965965

Group type: EXPERIMENTAL
Intervention: Cediranib 20 mg plus FOLFOX/CAPOX
Number of subjects: 860

Group type: COMPARATOR
Intervention: Placebo plus FOLFOX/CAPOX
Number of subjects: 860
Study: 19006537

Group type: EXPERIMENTAL
Intervention: Lubiprostone 8 mcg twice daily
Number of subjects: 1171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1171
Study: 17357862

Group type: EXPERIMENTAL
Intervention: Fibrin sealant application before drain insertion
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard Limberg flap technique
Number of subjects: 32
Study: 15194675

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study: 11489038

Group type: EXPERIMENTAL
Intervention: Qualitative research
Number of subjects: 0
Study: 8996340

Group type: EXPERIMENTAL
Intervention: 12-week prophylactic course of bacillus Calmette-Guerin (BCG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 6-week course of bacillus Calmette-Guerin (BCG)
Number of subjects: 70
Study: 8483096

Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue autografts (CTGs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Thick free gingival autografts (FGGs)
Number of subjects: 10
Study: 2825469

Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 11

Group type: COMPARATOR
Intervention: No-alcohol control
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Naloxone (6 mg/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 11
Study: 31707069

Group type: EXPERIMENTAL
Intervention: Patient + partner intervention
Number of subjects: 301

Group type: COMPARATOR
Intervention: Patient-only intervention
Number of subjects: 301
Study: 29292242

Group type: EXPERIMENTAL
Intervention: ticagrelor 90 mg twice daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: prasugrel 10 mg once daily
Number of subjects: 22
Study: 26460569

Group type: EXPERIMENTAL
Intervention: Smoking cessation treatment
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Nicotine craving increases
Number of subjects: 538
Study: 23963690

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) soybean, olive oil, and fish oil emulsion
Number of subjects: 130

Group type: COMPARATOR
Intervention: Parenteral soybean and olive oil emulsion (control)
Number of subjects: 130
Study: 22390886

Group type: EXPERIMENTAL
Intervention: Internet-delivered physical activity and healthy nutrition program with monthly email messages and additional web-based tools.
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Monthly email messages to promote website visits during the first year.
Number of subjects: 924

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 924
Study: 20869041

Group type: EXPERIMENTAL
Intervention: 20-week treatment for BED
Number of subjects: 179
Study: 19012472

Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (normal individuals)
Number of subjects: 40
Study: 16027343

Group type: EXPERIMENTAL
Intervention: Injected hyaluronidase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Injected hyaluronidase (3 different doses)
Number of subjects: 0
Study: 14709299

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 0.03% eyedrops
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Prednisolone 1% eyedrops
Number of subjects: 136

Group type: COMPARATOR
Intervention: Sodium chloride 0.9% eyedrops (placebo)
Number of subjects: 136
Study: 10633491

Group type: EXPERIMENTAL
Intervention: Amino acid (AA) mixture (n = 14)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tryptophan deficient mixture (n = 15)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Phenylalanine/tyrosine deficient mixture (n = 12)
Number of subjects: 41
Study: 9102029

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 20

Group type: COMPARATOR
Intervention: Radiographs
Number of subjects: 20
Study: 1281180

Group type: EXPERIMENTAL
Intervention: Fungal alpha-amylase and cellulase
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Bronchial challenge tests with alpha-amylase and cellulase
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Immunoblot analysis with pooled serum
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Reverse-enzyme immunoassay-inhibition assays
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Exposure to Aspergillus-derived enzymes as flour additives
Number of subjects: 5
Study: 6608052

Group type: EXPERIMENTAL
Intervention: Surgical therapy (coronary bypass surgery)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 780
Study: 30516416

Group type: EXPERIMENTAL
Intervention: Daily text message reminders (N = 42)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Weekly text message reminders (N = 37)
Number of subjects: 79
Study: 29757823

Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT) - ISWT-1
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT) - ISWT-2
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT) - ISWT-1 vs ISWT-3 after pulmonary rehabilitation (PR)
Number of subjects: 27
Study: 27040362

Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Low non-HDL-C level (≤140 mg/dl)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Low cholesterol group (≤140 mg/dl)
Number of subjects: 164
Study: 25130584

Group type: EXPERIMENTAL
Intervention: Tadalafil (phosphodiesterase enzyme-5 inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23307089

Group type: EXPERIMENTAL
Intervention: Pinaverium bromure and probiotics for 3 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Pinaverium bromure and placebo for 3 weeks
Number of subjects: 51
Study: 20077495

Group type: EXPERIMENTAL
Intervention: SRP+ERL (scaling and root planing followed by fluorescence controlled Er:YAG laser)
Number of subjects: 30

Group type: COMPARATOR
Intervention: SRP (scaling and root planing)
Number of subjects: 30
Study: 17611706

Group type: EXPERIMENTAL
Intervention: Mild vertebral fractures
Number of subjects: 3358

Group type: EXPERIMENTAL
Intervention: At least one grade >= 2 vertebral fracture at baseline
Number of subjects: 3358

Group type: EXPERIMENTAL
Intervention: Incident mild fractures only during the first 2 years
Number of subjects: 3358

Group type: EXPERIMENTAL
Intervention: At least one grade >= 2 incident fracture during the first 2 years
Number of subjects: 3358

Group type: EXPERIMENTAL
Intervention: Only mild vertebral fractures at baseline
Number of subjects: 3358

Group type: EXPERIMENTAL
Intervention: Patients aged more than 70 years with only mild vertebral fractures
Number of subjects: 3358

Group type: EXPERIMENTAL
Intervention: Patients aged more than 70 years with at least one grade >= 2 vertebral fracture
Number of subjects: 3358
Study: 15860392

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg/day for 3 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 11939924

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg/mL with sufentanil 0.75 microg/mL
Number of subjects: 114

Group type: COMPARATOR
Intervention: Bupivacaine 1.25 mg/mL with sufentanil 0.75 microg/mL
Number of subjects: 114
Study: 9830244

Group type: EXPERIMENTAL
Intervention: HIA-CP boys
Number of subjects: 0

Group type: COMPARATOR
Intervention: HIA-only boys
Number of subjects: 0

Group type: COMPARATOR
Intervention: non-HIA-CP boys
Number of subjects: 0

Group type: COMPARATOR
Intervention: CP only boys
Number of subjects: 0
Study: 7851363

Group type: EXPERIMENTAL
Intervention: Euhydrated with water ad libitum
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Euhydrated with no water intake (NW)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypohydrated (HY, -3.8 (SD 0.7)% body mass) with water ad libitum
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypohydrated (HY, -3.8 (SD 0.7)% body mass) with no water intake (NW)
Number of subjects: 10
Study: 2572140

Group type: EXPERIMENTAL
Intervention: 10 mg cetirizine nocte
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 60 mg terfenadine given morning and evening
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 1096829

Group type: EXPERIMENTAL
Intervention: Agar (600 mg/kg daily for 7 days, starting at 12 hours of age)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Agar (700 mg/kg daily for 7 days, starting at 6 hours of age)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no agar)
Number of subjects: 80
Study: 31812328

Group type: EXPERIMENTAL
Intervention: Genotype GG of rs7936070
Number of subjects: 1556

Group type: EXPERIMENTAL
Intervention: Genotype AA of rs7927894
Number of subjects: 1556

Group type: COMPARATOR
Intervention: C11orf30 expression in serum
Number of subjects: 1556
Study: 31034728

Group type: EXPERIMENTAL
Intervention: Simulation-based education on perioperative crises (Laryngospasm, Bronchospasm, Supraventricular Tachycardia (SVT), and Bradycardia) during the first week of an eight-week rotation (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Simulation-based education on perioperative crises during the fifth week of an eight-week rotation (Group B)
Number of subjects: 30
Study: 28851329

Group type: EXPERIMENTAL
Intervention: Additional daily school-time physical activity (PA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Villa Vitality (VV), a 6-week healthy lifestyle promotion programme
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall intervention implementation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Teacher logbooks vs researcher observations
Number of subjects: 24
Study: 25344064

Group type: EXPERIMENTAL
Intervention: Intravenous dantrolene (IV‐D) 1.25 mg every 6 hours for 7 days (n=16)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (equisosmolar free water/5% mannitol; n=15)
Number of subjects: 31
Study: 23842710

Group type: EXPERIMENTAL
Intervention: Darusentan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21950041

Group type: EXPERIMENTAL
Intervention: Epidrum (ED)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Loss of resistance (LOR)
Number of subjects: 40
Study: 20110024

Group type: EXPERIMENTAL
Intervention: Etizolam 0.5 mg BID
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 17007849

Group type: EXPERIMENTAL
Intervention: 1 mg anastrozole for 5 days (cycle days 3‐7) followed by FSH injections (days 7‐11)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 100 mg clomiphene citrate for 5 days (cycle days 3‐7) followed by FSH injections (days 7‐11)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1 mg anastrozole
Number of subjects: 50

Group type: COMPARATOR
Intervention: 100 mg clomiphene citrate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Clomiphene citrate cycles
Number of subjects: 50